AMSTERDAM, Feb 15 (Reuters) - Dutch specialty chemicals
maker DSM DSMN.AS on Tuesday beat analyst expectations with a
13% jump in fourth-quarter core profit to 440 million euros
($497.95 million), as demand for its nutritional products
remained strong despite higher prices.
Analysts in a company-compiled poll on average had predicted
adjusted earnings before interest, taxes, depreciation and
amortisation (EBITDA) would rise to 424 million euros, from 390
million a year before.
($1 = 0.8836 euros)
(Reporting by Bart Meijer; Editing by Himani Sarkar)
((Bart.Meijer@thomsonreuters.com; +31 20 504 5006; Reuters
Messaging: bart.meijer@thomsonreuters.com))